Quantbot Technologies LP bought a new stake in shares of National HealthCare Co. (NYSE:NHC - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 2,987 shares of the company's stock, valued at approximately $277,000.
Several other institutional investors and hedge funds also recently made changes to their positions in NHC. GAMMA Investing LLC lifted its stake in National HealthCare by 10,510.2% during the first quarter. GAMMA Investing LLC now owns 31,088 shares of the company's stock worth $2,885,000 after purchasing an additional 30,795 shares during the last quarter. Nuveen LLC acquired a new stake in National HealthCare in the first quarter worth $2,721,000. Sovereign s Capital Management LLC acquired a new stake in National HealthCare in the fourth quarter worth $2,632,000. First Trust Advisors LP increased its position in National HealthCare by 75.6% in the fourth quarter. First Trust Advisors LP now owns 47,062 shares of the company's stock worth $5,062,000 after buying an additional 20,268 shares during the period. Finally, Alps Advisors Inc. increased its position in National HealthCare by 7.7% in the first quarter. Alps Advisors Inc. now owns 147,800 shares of the company's stock worth $13,716,000 after buying an additional 10,614 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
National HealthCare Price Performance
NYSE:NHC traded up $0.31 during mid-day trading on Monday, reaching $113.48. 33,723 shares of the stock were exchanged, compared to its average volume of 58,129. The business has a fifty day moving average price of $103.69 and a 200 day moving average price of $99.50. The firm has a market capitalization of $1.76 billion, a PE ratio of 14.22 and a beta of 0.58. National HealthCare Co. has a 1-year low of $89.14 and a 1-year high of $137.53. The company has a current ratio of 1.80, a quick ratio of 1.77 and a debt-to-equity ratio of 0.14.
National HealthCare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.64 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $2.56 dividend on an annualized basis and a dividend yield of 2.3%. National HealthCare's dividend payout ratio (DPR) is 38.15%.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised National HealthCare from a "buy" rating to a "strong-buy" rating in a report on Monday, May 12th.
Get Our Latest Stock Analysis on National HealthCare
About National HealthCare
(
Free Report)
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Further Reading

Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.